Nacresertib

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H26N4O4
Molecular Weight	410.4662
Optical Activity	NONE
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0
Stereo Comments	CIS/TRANS substitution

SHOW SMILES / InChI

Structure Search

SMILES

COC1=CC2=NN(C=C2C=C1NC(=O)C3=CC=CC(C)=[N+]3[O-])[C@H]4CC[C@](C)(O)CC4

InChI

InChIKey=XYPANWHZPSKPMX-CIEDQVTBSA-N

InChI=1S/C22H26N4O4/c1-14-5-4-6-19(26(14)29)21(27)23-18-11-15-13-25(24-17(15)12-20(18)30-3)16-7-9-22(2,28)10-8-16/h4-6,11-13,16,28H,7-10H2,1-3H3,(H,23,27)/t16-,22-

HIDE SMILES / InChI

Approval Year

Name

Type

Language

Nacresertib

Official Name

English

2-({2-[(1r,4r)-4-hydroxy-4-methylcyclohexyl]-6-methoxy-2H-indazol-5-yl}carbamoyl)-6-methylpyridine 1-oxide

Preferred Name

English

2-PYRIDINECARBOXAMIDE, N-(2-(TRANS-4-HYDROXY-4-METHYLCYCLOHEXYL)-6-METHOXY-2H-INDAZOL-5-YL)-6-METHYL-, 1-OXIDE

Systematic Name

English

nacresertib [INN]

Common Name

English

Code System Code Type Description

INN

13134

Created by admin on Wed Apr 02 12:46:28 GMT 2025 , Edited by admin on Wed Apr 02 12:46:28 GMT 2025

PRIMARY

NCI_THESAURUS

C213407

Created by admin on Wed Apr 02 12:46:28 GMT 2025 , Edited by admin on Wed Apr 02 12:46:28 GMT 2025

PRIMARY

CAS

2629977-59-7

Created by admin on Wed Apr 02 12:46:28 GMT 2025 , Edited by admin on Wed Apr 02 12:46:28 GMT 2025

PRIMARY

FDA UNII

MB3QBD4BE7

Created by admin on Wed Apr 02 12:46:28 GMT 2025 , Edited by admin on Wed Apr 02 12:46:28 GMT 2025

PRIMARY

ACTIVE MOIETY


					MB3QBD4BE7

Nacresertib